The 5 analysts offering 12-month price forecasts for ADC Therapeutics SA have a median target of 6.00, with a high estimate of 12.00 and a low estimate of 2.00. The median estimate represents a +650.00% increase from the last price of 0.80.
The current consensus among 7 polled investment analysts is to Buy stock in ADC Therapeutics SA. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.69
Reporting Date Nov 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.